Liaison International

Liaison operates Centralized Application Services (CAS) for graduate health professions — including medicine, dentistry, public health, and physician assistant studies. Applicant fees and institutional subscriptions drive recurring revenue. The firm also provides enrollment-marketing and CRM tools to higher-education institutions. The combination creates a data-rich, high-switching-cost business anchored in academic accreditation workflows.

The firm has been owned by private equity firm Welsh, Carson, Anderson & Stowe since its acquisition in 2016 (public record). Founder George Haddad continues as CEO. The private equity backing supports acquisition-led growth, including the 2022 purchase of TargetX from Anthology to deepen its CRM capabilities.

Over 1,200 campuses and 31,000 programs use Liaison-powered application services, spanning schools of medicine, dentistry, optometry, public health, pharmacy, and physician assistant studies. Most programs are in the United States and Canada. The firm processes north of 3.5 million applications annually across its various CAS platforms.

Its market position is structurally sourced: health-profession associations mandate centralized application services as part of accreditation. Liaison is the designated CAS operator for numerous associations, embedding it directly into the required workflow for every applicant. This regulatory-adjacent integration creates exceptional retention and near-zero churn among member schools.

Unlike general enrollment CRMs, Liaison's product is the application gateway itself. It aggregates and verifies transcripts, test scores, and recommendations before programs ever touch the data. This makes Liaison a quasi-utility for graduate health education rather than a discretionary software purchase. The firm's data assets — longitudinal applicant trends, diversity metrics, and program-demand signals — are increasingly monetized separately from the application-processing fees.